BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 16967455)

  • 1. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
    Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
    J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
    Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
    Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it time for a new TNM classification in esophageal carcinoma?
    Bogoevski D; Onken F; Koenig A; Kaifi JT; Schurr P; Sauter G; Izbicki JR; Yekebas EF
    Ann Surg; 2008 Apr; 247(4):633-41. PubMed ID: 18362626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
    Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
    Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
    Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
    Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
    Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
    J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
    Bollschweiler E; Baldus SE; Schröder W; Prenzel K; Gutschow C; Schneider PM; Hölscher AH
    Endoscopy; 2006 Feb; 38(2):149-56. PubMed ID: 16479422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.